Skip to main content

Table 1 Clinical and demographic characteristics of eligible patients in studies of the National Antimalarial Drug Resistance Monitoring System, northeast India, 2012-13

From: Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India

Study site

Lunglei (Mizoram)

Gomati (Tripura)

Changlang (Arunachal Pradesh)

Characteristic

(N = 66)

(N = 72)

(N = 37)

Sex (no (%))

   

Male

39 (59.1)

39 (54.2)

22 (59.5)

Female

27 (40.9)

33 (45.8)

15 (40.5)

Age category (no (%))

   

< 5 yr

6 (9.1)

24 (33.3)

7 (18.9)

5-15 yr

26 (39.4)

30 (41.7)

18 (48.6)

Adult

34 (51.5)

18 (25.0)

12 (32.4)

Temperature (˚C)

   

Mean ± SD

36.3 ± 1.3

38.1 ± 0.4

38.2 ± 0.5

Range

36.2-39.3

37.5 - 39.2

(37.5 - 39.1)

Febrile (≥ 37.5)

   

Yes (no (%))

13 (19.7)

72 (100.0)

37 (100.0)

No (no (%))

53 (80.3)

-

-

Parasite count (no/μl)a

   

Mean ± SD

18899.3 ± 23979.5

18507.6 ± 20937.3

31186.5 ± 27451.6

< 5,000

22 (33.3)

26 (36.1)

7 (18.9)

5,000-50,000

36 (54.5)

37 (51.4)

20 (54.1)

≥ 50,000

8 (12.1)

9 (12.5)

10 (27.0)

Gametocytes on day 0

   

(no (%))

3 (4.2)

17 (23.9)

12 (32.4)

Number of mutations

   

0-2

6 (9.1)

3 (4.2)

1 (2.7)

2-4

4 (6.1)

5 (6.9)

2 (5.4)

≥ 5

56 (84.8)

64 (88.9)

34 (91.9)

  1. aAt enrolment, before treatment.